In patients with decompensated cirrhosis, sarcopenia and frailty are prevalent. Although
several definitions exist for these terms, in the field of hepatology, sarcopenia has commonly …

Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such
as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C …

This is the first American Association for the Study of Liver Diseases (AASLD) practice
guidance on the management of malnutrition, frailty, and sarcopenia in patients with …

Funding for the development of this Practice Guidance was provided by the American
Association for the Study of Liver Diseases. MV was supported by aAQ19 Patient-Centered …

Sarcopenia (severe muscle depletion) is a prevalent muscle abnormality in patients with
cirrhosis that confers poor prognosis both pre-and post-liver transplantation. The …

Loss of muscle mass and function, or sarcopenia, is a common feature of cirrhosis and
contributes significantly to morbidity and mortality in this population. Sarcopenia is a main …

Background Malnutrition/sarcopenia and frailty are common in patients with cirrhosis and
are associated with poor outcomes. Aim To provide an overview of data on the importance …

Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …

Frailty has emerged as a powerful predictor of outcomes in patients with cirrhosis and has
inevitably made its way into decision making within liver transplantation. In an effort to …

Abstract Changes in body composition are associated with poor outcomes in cancer patients
including hepatocellular carcinoma (HCC). Sarcopenia, defined as the loss of skeletal …